When Ms. Zhang was diagnosed with advanced pancreatic cancer and lung metastases, her family sought a second opinion from MD Anderson before flying to the U.S. Through Medebound HEALTH, they secured a timely remote consultation with a leading pancreatic cancer expert. The result: new treatment direction, clinical trial eligibility, and personal care from a top U.S. oncologist offering renewed hope in a time of urgency.

A 56-year-old woman from China facing a rare and aggressive metaplastic breast cancer received renewed hope through a remote second opinion from MSKCC, coordinated by Medebound HEALTH. The expert consultation led to a personalized treatment plan involving antibody-drug conjugates, immunotherapy, and a detailed monitoring strategy, demonstrating the power of international collaboration in complex cancer care.